This is

Bayer in Canada

Bayer in Canada

In this age of rapid change, we strive to deliver the world’s best solutions to global challenges in the fields of health and nutrition.

With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.

In Canada, we have over 1,400 passionate and innovative employees. As a Life Science company we have three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health and Radiology business units.  We are committed to operating sustainably and addressing our social and ethical responsibilities. As we continue to shape our industry, our efforts are catalyzed by focusing on our customers. All of this makes up our corporate purpose: Science for a better life.

News

September 18, 2018

New indication will help Canadians with coronary artery disease prevent heart attack, stroke or death

Rivaroxaban (XARELTO®) 2.5 mg twice daily in combination with acetylsalicylic acid (ASA) 75 mg -100 mg once daily offers a new way to treat Canadians with coronary artery disease Read more
July 17, 2018

Bayer launches Olympus, the premier pre-seed foxtail barley solution for growers across the Prairies

Read more
Bayer News Overview